TELA Bio (TELA) FCF Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
TELA Bio (TELA) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | 884.00 |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | 503.00 |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 646.00 |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | 534.00 |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | 919.00 |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | 3,472.00 |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | 353.00 |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | -97.00 |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | 60.00 |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn | 2,986.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,986.00 |
| Mar 31, 2026 | 3,892.00 |
| Dec 31, 2025 | 7,113.00 |
| Sep 30, 2025 | 4,248.00 |
| Jun 30, 2025 | 7,452.00 |
| Mar 31, 2025 | 7,811.00 |
| Dec 31, 2024 | 7,378.00 |
| Sep 30, 2024 | 4,229.00 |
| Jun 30, 2024 | 658.00 |
| Mar 31, 2024 | 5,799.00 |
| Dec 31, 2023 | 5,981.00 |
| Sep 30, 2023 | 2,289.00 |
| Jun 30, 2023 | 10,321.00 |
| Mar 31, 2023 | 9,978.00 |
| Dec 31, 2022 | 5,348.00 |
| Sep 30, 2022 | 6,558.00 |
| Jun 30, 2022 | 4,460.00 |
| Mar 31, 2022 | 10,589.00 |
| Dec 31, 2021 | 12,037.00 |